An Open-Label Extension Study for Participants who Completed Study IMVT-1401-3201 or Study IMVT-1401-3202 to Assess the Efficacy and Safety of Batoclimab for the Treatment of Thyroid Eye Disease (TED)
Oculoplastics
IMVT TED
A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
Kikkawa honored as 2022 Distinguished Alumni
Don O. Kikkawa, MD, FACS is the recipient of the 2022 UW-Madison Ophthalmology Alumni Association’s Distinguished Alumni Award. Kikkawa, who completed his fellowship in oculoplastics at UW-Madison in 1992, said he was drawn to the …
TED
A Phase 2b, Randomized, Double-Mask, Placebo-Controlled, Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Linsitinib in Subjects with Active, Moderate to Severe Thyroid Eye Disease (TED)